Back to Search
Start Over
Advanced EGFR-mutant NCSLC resistant to osimertinib therapy as a result of a novel CGN-RET fusion mutation with favorable response to combined osimertinib and selpercaptinib, case report
- Source :
- Current Problems in Cancer: Case Reports. 11:100246
- Publication Year :
- 2023
- Publisher :
- Elsevier BV, 2023.
- Subjects :
- Oncology
Subjects
Details
- ISSN :
- 26666219
- Volume :
- 11
- Database :
- OpenAIRE
- Journal :
- Current Problems in Cancer: Case Reports
- Accession number :
- edsair.doi...........43f6ef4996511a1a49f84dde4c2f6c9d